Smith G - Search Results

1

Alzheimer disease: measuring loss of cerebral gray matter with MR imaging.

Rusinek H, de Leon MJ, George AE, Stylopoulos LA, Chandra R, Smith G, Rand T, Mourino M, Kowalski H. Rusinek H, et al. Among authors: smith g. Radiology. 1991 Jan;178(1):109-14. doi: 10.1148/radiology.178.1.1984287. Radiology. 1991. PMID: 1984287

2

CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex.

George AE, de Leon MJ, Stylopoulos LA, Miller J, Kluger A, Smith G, Miller DC. George AE, et al. Among authors: smith g. AJNR Am J Neuroradiol. 1990 Jan-Feb;11(1):101-7. AJNR Am J Neuroradiol. 1990. PMID: 2105589 Free PMC article.

3

The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation.

de Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, McRae T, De Santi S, Smith G, Ferris SH, Noz M, et al. de Leon MJ, et al. Among authors: smith g. AJNR Am J Neuroradiol. 1993 Jul-Aug;14(4):897-906. AJNR Am J Neuroradiol. 1993. PMID: 8352162 Free PMC article.

4

Early marker for Alzheimer's disease: the atrophic hippocampus.

de Leon MJ, George AE, Stylopoulos LA, Smith G, Miller DC. de Leon MJ, et al. Among authors: smith g. Lancet. 1989 Sep 16;2(8664):672-3. doi: 10.1016/s0140-6736(89)90911-2. Lancet. 1989. PMID: 2570916 Free article. No abstract available.

5

Mild cognitive impairment and Alzheimer disease: regional diffusivity of water.

Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC. Kantarci K, et al. Among authors: smith ge. Radiology. 2001 Apr;219(1):101-7. doi: 10.1148/radiology.219.1.r01ap14101. Radiology. 2001. PMID: 11274543 Free PMC article.

6

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.

Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A, et al. Bartlett EJ, et al. Among authors: smith g. Am J Psychiatry. 1994 May;151(5):681-6. doi: 10.1176/ajp.151.5.681. Am J Psychiatry. 1994. PMID: 8166309

7

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.

8

Gray-matter degeneration in presenile Alzheimer's disease.

Prohovnik I, Smith G, Sackeim HA, Mayeux R, Stern Y. Prohovnik I, et al. Among authors: smith g. Ann Neurol. 1989 Feb;25(2):117-24. doi: 10.1002/ana.410250203. Ann Neurol. 1989. PMID: 2919865

9

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease.

Prohovnik I, Mayeux R, Sackeim HA, Smith G, Stern Y, Alderson PO. Prohovnik I, et al. Among authors: smith g. Neurology. 1988 Jun;38(6):931-7. doi: 10.1212/wnl.38.6.931. Neurology. 1988. PMID: 3368076

10

Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain.

Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Volkow ND, Wolf AP, Smith G, Wolkin A, Cancro R. Bartlett EJ, et al. Among authors: smith g. Psychiatry Res. 1996 Mar 29;60(2-3):91-9. doi: 10.1016/0165-1781(96)02711-4. Psychiatry Res. 1996. PMID: 8723299 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,512 results

Search Page

Filters